Clinical Application of New Technologies for the Premalignant Lesions of Oral Squamous Cell Carcinoma (OSCC) and the Early Diagnosis of OSCC

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500096011

Enrollment

Unknown

Registered

2025-01-16

Start date

2025-02-01

Completion date

Unknown

Last updated

2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with oral squamous cell carcinoma

Interventions

Gold Standard:qRT-PCR

Index test:RTF-EXPAR-CRISPR/Cas12a-Three-Dimensional (3D) DNA Nanonet Biosensor Detection

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age = 18; 2.Pathologically diagnosed with oral squamous cell carcinoma or having already undergone oral squamous cell carcinoma resection.

Exclusion criteria

Exclusion criteria: 1.Systemic diseases such as diabetes; 2.History of orthodontic treatment; 3.Female pregnancy;

Design outcomes

Primary

Measure	Time frame
The concentration of miRNA;	—

Secondary

Measure	Time frame
Linear range;sensitivity;specificity;	—

Countries

China

Contacts

Public ContactGang Tian

The affiliated hospital of southwest medical university

tiangang@swmu.edu.cn+86 18244362063

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026